Arkolith/Insider Trading/ANAB/Form 4

Lizzul Paul F.

Chief Medical OfficerANAPTYSBIO, INC (ANAB) · full profile →Form 4 · filed Jan 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$163K
Net Open-Market Flow
-$163K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2026Sell(S)4K$44.71$163K42K
Jan 7, 2026Option exercise(M)9K——46K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)9K—$026K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001711462-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML